MRNA

Biotechnology MRNA Uncategorized

Moderna downgraded to neutral at UBS on questions over revenue growth

Jan 6, 2026

AZN Biotechnology BNTX GCVRZ GSK MRK MRNA NVAX PFE SNY SNYNF Uncategorized

CDC updates childhood vaccine schedule to recommend fewer shots

Jan 5, 2026

Biotechnology MRNA Uncategorized

Moderna seeks global approvals for flu shot

Jan 5, 2026

Biotechnology MRNA Uncategorized

Moderna granted up to $54.3M from CEPI for bird flu vaccine

Dec 18, 2025

Biotechnology BNTX MRNA NVAX PFE Uncategorized

FDA Commissioner Makary says ‘black box’ warning not coming to COVID vaccines

Dec 15, 2025

Biotechnology BMY CYTK GSK IBRX MRK MRNA NONOF NVO Uncategorized

ImmunityBio, Moderna among winners of EU drug recommendations this week

Dec 12, 2025

moderna-on-track-to-extend-gains-for-the-seventh-straight-trading-day

Biotechnology MRNA Uncategorized

Moderna on track to extend gains for the seventh straight trading day

Dec 11, 2025

On the Move Comment (1) Moderna (NASDAQ:MRNA) extended gains for the seventh consecutive trading session,...

« Previous Page